30 Result(s)
within
Osamu Kinoshita
Nephrology
-
Article
EVAHEART 2 with double cuff tipless inflow cannula is suitable for long-term support atrial switch operation in transposition of great arteries
Implantation of continuous-flow left ventricular assist device in a narrow lumen is technically challenging to secure an optimal support. We experienced a patient with the transposition of the great arteries a...
-
Article
Open AccessA case of cardiogenic shock due to acute coronary syndrome successfully recovered by percutaneous and paracorporeal left ventricular assist device
We recently experienced a 70-year-old woman with left main trunk-acute coronary syndrome who was initially supported by Impella 5.0 which converted to paracorporeal left ventricular assist device (LVAD) implan...
-
Article
Single-center experience of the bridge-to-bridge strategy using the Nipro paracorporeal ventricular assist device
Currently, we use the Nipro paracorporeal VAD (p-VAD) for initial short-term ventricular support, as a bridge to decision (BTD) or a bridge to candidacy (BTC) treatment, in Interagency Registry for Mechanicall...
-
Article
Readmissions after continuous flow left ventricular assist device implantation
Continuous flow left ventricular assist device (CF-LVAD) therapy has improved the survival of patients with advanced heart failure. However, the readmission rate of CF-LVAD patients is still relatively high. A...
-
Article
Correlation between driveline features and driveline infection in left ventricular assist device selection
Although the survival rate for left ventricular assist device (LVAD) therapy has improved, device-related complications are an unpredictable threat to the patient’s quality of life. We focused on driveline inf...
-
Article
Central aortic valve closure successfully treated aortic insufficiency of the patient with Jarvik 2000 continuous flow left ventricular assist device: a case report
Aortic insufficiency (AI) is a significant complication of long-term support of continuous flow left ventricular assist device (CF-LVAD) for patients with end-stage heart failure. A 26-year-old female with ost...
-
Article
Successful management of apical abscess after Nipro left ventricular assisted device explantation by removal of apical cuff and omentopexy
Nipro-Toyobo-paracorporeal pulsatile flow VAD (Nipro VAD; Nipro, Osaka, Japan) has been used most commonly as a paracorporeal VAD (p-VAD) in Japan. There are few reports describing clinical course of post LVAD...
-
Article
A delayed splenic rupture after transcatheter arterial embolization required total splenectomy in a patient with an implantable left ventricular assist device
We successfully managed a splenic injury and delayed splenic rupture in a patient with an implantable left ventricular assist device (iLVAD). A 42-year-old man with an iLVAD for idiopathic dilated cardiomyopat...
-
Article
A successful management of infection of the left ventricular assist device by pump exchange: conversion from DuraHeart to Jarvik 2000
We successfully controlled infection of a left ventricular assist device by performing pump exchange. A 53-year-old man was implanted with DuraHeart for ischemic cardiomyopathy as a bridge to transplantation. ...
-
Article
Reversible decline in pulmonary function during left ventricular assist device therapy
Cardiac replacement therapy, consisting of left ventricular assist device (LVAD) implant surgery and heart transplantation, has considerably reduced the mortality and morbidity of patients with stage D heart f...
-
Article
Is cardiopulmonary exercise testing essential to indicate ventricular assist device implantation in patients with INTERMACS profile 4–7?
Cardiopulmonary exercise testing (CPXT) is a promising tool for predicting 2-year cardiac death or ventricular assist device (VAD) implantation in patients assigned to INTERMACS profile 4–7. However, CPXT is n...
-
Article
Preoperative iodine-123 meta-iodobenzylguanidine imaging is a novel predictor of left ventricular reverse remodeling during treatment with a left ventricular assist device
Although left ventricular reverse remodeling (LVRR) is accompanied with an improved clinical course during LV assist device (LVAD) treatment, its preoperative prediction remains uncertain. Twenty-seven heart f...
-
Article
High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement
Although the right ventricular stroke work index (RVSWI) is a good index for RV function, a low RVSWI is not necessarily an indicator for the need for a right ventricular assist device at the time of left VAD...
-
Article
Biventricular failure with low pulmonary vascular resistance was managed by left ventricular assist device alone without right-sided mechanical support
How to manage preoperative right ventricular dysfunction (RVD) in heart failure patients without cardiogenic shock remains as a matter to be debated because implantable biventricular assist device treatment ha...
-
Article
Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support
Survival in patients with continuous flow left ventricular assist device (CF LVAD) had been increased owing to improved perioperative management procedures. The second target for successful long-term LVAD trea...
-
Article
Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment
Although the suppression of sympathetic activity is an essential mission for the current heart failure treatment strategy, little is known about the relationship between the rotation speed setting and autonomi...
-
Article
Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery
To date, there have been few reports demonstrating preoperative predictors for left ventricular reverse remodeling (LVRR) after LV assist device (LVAD) implantation, especially among patients with dilated card...
-
Article
Four-year paracorporeal left ventricular assist device (LVAD) support for heart failure after Rastelli operation
It is well known that heart failure can occur after a conventional Rastelli operation (using an anatomical right ventricle as a systemic ventricle) in patients with congenitally corrected transposition of the ...
-
Article
Successful weaning from the DuraHeart with a low left ventricular ejection fraction
We report a case in which the DuraHeart (Terumo Heart, Ann Arbor, MI, USA) was successfully removed despite a low ejection fraction. A 33-year-old man who suffered from dilated cardiomyopathy underwent implant...
-
Article
Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation
There has been no established medical therapy to ameliorate pulmonary hypertension (PH) owing to left heart disease (LHD-PH). It has recently been shown that the left ventricular assist device (LVAD) can impro...
